Close
American Drug Delivery & Formulation Summit

Digital Tech Gaining Ground In Boosting Women Healthcare

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

CDSCO to Introduce Integrated Drug Regulatory Platform in 18 Months

The Central Drugs Standard Control Organisation (CDSCO) has announced...

Resilience and Eli Lilly Expand Strategic Partnership with $750 Million Ohio Manufacturing Investment

Resilience has announced an expansion of its strategic partnership...

WHO Introduces Global Regulatory Framework for Decarbonizing Pharmaceuticals

The World Health Organization (WHO) has officially launched the...
- Advertisement -

Womenโ€™s health has often been overlooked despite involving 50% of the population. However, there is growing recognition of the differences in health needs and outcomes between men and women. Scientific breakthroughs, new technologies, and policies provide unique opportunities to improve womenโ€™s health and reduce societal and economic costs.

In our digital era, data holds immense value as it drives innovation, growth, and progress. The challenges in womenโ€™s healthcare are extensive and intricate, but leveraging evolving technologies, especially those focused on data collection, can lead to better, faster, and more efficient healthcare for women. Without measurement and adjustment, improvements are difficult to achieve.

AI has significantly improved womenโ€™s health by reducing medical errors, providing accurate predictions, and making healthcare more efficient. It aids in the early detection of cancer by identifying hidden abnormalities and helps identify disorders like gestational diabetes and congenital birth defects, leading to improved pregnancy outcomes.

AI has evolved in screening programs, serving as a decision support tool in breast cancer imaging and enabling more intensive screening and preventative techniques. It also creates digital images of cervical smear slides to detect Human Papilloma Virus (HPV), the main cause of cervical cancers.

The UK Governmentโ€™s ยฃ16 million investment in AI companies for diagnosis and treatment reflects the industryโ€™s direction. Efficient screening programs are crucial, and AI, along with increased data capture, continues to play a dominant role in detecting, diagnosing, and enhancing womenโ€™s health outcomes.

Personalized healthcare, tailored to individual factors, is crucial for womenโ€™s health. AI technology is advancing risk stratification for more targeted treatments. Recent investments in AI technology have focused on determining the risk of pre-eclampsia and assessing breast cancer risk.

Digital technology is transforming womenโ€™s health with the rise of accessible apps, online trackers, and wearable devices. This growth fuels the femtech industry, empowering women to lead healthier lives. Femtech apps offer convenient care options like virtual clinics and prescription delivery, while wearable technology and menstruation-tracking apps are popular among millions of women worldwide. The vast data captured holds great potential for innovative healthcare solutions that address cultural and structural barriers.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Latest stories

Related stories

CDSCO to Introduce Integrated Drug Regulatory Platform in 18 Months

The Central Drugs Standard Control Organisation (CDSCO) has announced...

Resilience and Eli Lilly Expand Strategic Partnership with $750 Million Ohio Manufacturing Investment

Resilience has announced an expansion of its strategic partnership...

WHO Introduces Global Regulatory Framework for Decarbonizing Pharmaceuticals

The World Health Organization (WHO) has officially launched the...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป